A daily dose of 400 mg efavirenz (EFV) is non-inferior to the standard 600 mg dose: week 48 data from the ENCORE1 study, a randomised, double-blind, placebo.
Can dose-optimization trials be conducted ethically in low-income countries? Dr Andrew Hill World AIDS Conference, Melbourne, Australia July 2014 [TUWS1104]
Encore1 study design
![Can dose-optimization trials be conducted ethically in low-income countries? Dr Andrew Hill World AIDS Conference, Melbourne, Australia July 2014 [TUWS1104]](https://static.fdocuments.in/doc/330x215/56649d705503460f94a52ae7/can-dose-optimization-trials-be-conducted-ethically-in-low-income-countries.jpg)
